Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide and Dexamethasone in AL Amyloidosis
NCT01510613Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Feb 2012
- Primary completion
- Dec 2016
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pomalidomide in amyloid light chain amyloidosis, sponsored by IRCCS San Matteo Foundation. Primary endpoint: Efficacy of PDex. Started Feb 2012; status: completed.
02
Drugs
pomalidomide
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT01510613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510613.